rcca-header
Clinical Trials

A Phase 2 Study of Nivolumab and Brentuximab Vedotin Consolidation After Autologous Stem Cell Transplantation in Patients with High-Risk Classical Hodgkin Lymphoma

Type of Cancer
Lymphoma
Site
Hackensack
Sponsor
City of Hope
Protocol Number
City of Hope COH 16378
To Learn More Call
(201)-510-0950